Posted: October 2017
Jean-Charles Soria, MD, PhD, has been appointed Senior Vice President, Head of Oncology Innovative Medicines at MedImmune, AstraZeneca. He will oversee research, translational sciences and early drug development in oncology within MedImmune. Prior to this appointment, Dr. Soria served as a Professor of Medicine and Medical Oncology at South-Paris University. He was also a tenure-track and full-time cancer specialist at the Institut Gustave Roussy where he served as Chair of the Drug Development Department and a member of the lung cancer unit with a focus on targeted therapies. Dr. Soria is Editor-in-Chief of the Annals of Oncology.